Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics
Accesswire
*Group includes leading experts in multiple disciplines including immunology, liver diseases, protein engineering, antibody drug..